Orchestra BioMed Holdings Financial Overview
Orchestra BioMed Holdings's market cap is currently $243.93M. The company's EPS TTM is $-0.4; its P/E ratio is -2.38; Orchestra BioMed Holdings is scheduled to report earnings on November 18, 2025, and the estimated EPS forecast is $-0.38. See an overview of income statement, balance sheet, and cash flow financials.
